SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

Investors are actively debating the legitimacy of various crypto tokens attempting to capitalize on the highly anticipated, multi-trillion dollar SpaceX IPO. While some participants are seeking exposure through the tokenized assets, others are warning of a potential scam, urging caution against the speculative hype surrounding Elon Musk's companies.

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Assertio Holdings Inc

Assertio Holdings is trending as investors scrutinize the company's $125 million acquisition by Garda Therapeutics at $18 per share, which many long-term shareholders feel significantly undervalues the core Rolvedon asset and follows a series of questionable portfolio divestitures. The community remains highly vocal about potential fiduciary failures, expressing intense frustration over management's decision-making and demanding accountability while waiting for the Schedule 14D-9 to clarify the valuation process.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is generating significant interest as investors weigh its tech-heavy exposure and monthly dividend yield against market volatility, with the community actively debating whether to hold the fund for consistent income or rotate into higher-yielding alternatives. Traders are closely monitoring a psychological price barrier near $60, viewing the recent market fluctuations as a potential entry point for long-term positions.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is experiencing significant volatility and downward pressure as investors navigate sector-wide weakness and frustration over the stock's inability to maintain gains despite steady contract wins. While the community is actively debating whether the stock has bottomed or needs more time to heal, many remain bullish on the long-term outlook, highlighting strong fundamental backlog and the company's role in government, nuclear, and space infrastructure as key reasons to maintain their positions.

4DMT operates as a clinical-stage genetic medicines company focused on inventing and developing genetic medicines to treat large market diseases in ophthalmology, pulmonology and cardiology. It develops genetic medicines using its proprietary invention platform, Therapeutic Vector Evolution. It combines the power of the Nobel Prize-winning technology, directed evolution, with approximately one billion synthetic AAV capsid-derived sequences. Its product design, development and manufacturing engine create a valuable and diverse product pipeline. The company is currently advancing five clinical-stage and two preclinical product candidates, each tailored to address rare and large market diseases. 4DMT was founded by David H. Kirn, Melissa Kotterman, Theresa Janke, and David Schaffer on September 12, 2013 and is headquartered in Emeryville, CA.

4D Molecular Therapeutics Inc

4D Molecular Therapeutics is attracting significant attention as investors react to positive Phase 2 SPECTRA trial data for 4D-150 in diabetic macular edema, sparking discussions about its potential as a best-in-class, durable gene therapy. While the community is actively debating the company's valuation relative to its cash position and the timeline for upcoming pivotal data, momentum traders are closely monitoring price action and short interest as the company prepares for upcoming investor conferences.

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. The Generics, Established Brands, and Other segment consists of contract manufactured products, development services, royalties, and other. The Rare Disease segment involves the operations related to Cortrophin Gel. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

ANI Pharmaceuticals Inc

ANI Pharmaceuticals is experiencing positive momentum driven by strong demand for its rare disease franchise, particularly Cortrophin Gel, and a robust pipeline of new product launches. The community is actively discussing the company's improved financial guidance and strategic efforts to scale its rare disease portfolio, while some remain cautious about broader sector headwinds and historical share price performance.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores, Inc.

Casey's General Stores is seeing significant investor attention driven by strong performance in its food and beverage segments, which are proving to be major traffic drivers alongside its core fuel business. The community is actively discussing its recession-proof business model and potential for further market expansion, keeping the stock a popular pick for those seeking quality and stability in a volatile environment.

Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG - ADR

Fresenius Medical Care AG & Co. KGAA

Fresenius Medical Care is trending as investors monitor the company's progress with its DefenCath infection-prevention initiative, which the community highlights for its potential to improve patient outcomes and drive operating efficiency. Discussions are heavily focused on the company's role as a major player in the dialysis sector and how its operational strategies, including potential acquisitions and cost-saving measures, may influence its long-term market position.

Modine Manufacturing Co. engages in the provision of thermal management products and solutions. It operates through the Climate Solutions and Performance Technologies business segments. The Climate Solutions segment provides climate-controlled solutions and components, heat transfer products, heating, ventilating, air conditioning and refrigeration products, and data center cooling solutions. The Performance Technologies segment designs and manufactures air- and liquid-cooled technology for vehicular, stationary power, and industrial applications. In addition, the Performance Technologies segment provides thermal solutions to zero-emission and hybrid commercial vehicle and automotive customers, and coating products and application services. The company was founded by Arthur B. Modine on June 23, 1916 and is headquartered in Racine, WI.

Modine Manufacturing Co.

Modine Manufacturing is capturing intense investor attention as it positions itself as a pure-play leader in data center thermal management, a critical infrastructure bottleneck for the surging AI and hyperscale compute sector. The community is actively debating the company's valuation against its aggressive growth targets and upcoming spinoff, with many tracking it alongside industry peers as a key play on physical AI infrastructure.

Vishay Intertechnology, Inc. engages in the manufacture and distribution of discrete semiconductors and passive electronic components. It operates through the following segments: MOSFET (metal oxide semiconductor field-effect transistor), Diodes, Optoelectronic Components, Resistors, Inductors, and Capacitors. The MOSFET segment offers semiconductors which function as solid state switches to control power. The Diodes segment produces semiconductors which route, regulate, and block radio frequency, analog, and power signals, protect systems from surges or electrostatic discharge damage, and provide electromagnetic interference filtering. The Optoelectronic Components segment includes components that emit light, detect light, or do both. The Resistors and Inductors segment deals with components that impede electric current. The Capacitors segment provides components which store energy and discharge it when needed. The company was founded by Felix Zandman in 1962 and is headquartered in Malvern, PA.

Vishay Intertechnology, Inc.

Vishay Intertechnology is attracting significant investor interest as a foundational semiconductor recovery play, driven by robust call option activity and its strategic positioning in high-growth infrastructure sectors like smart home sensing and grid modernization. The community is actively discussing its potential for structural growth as the company transitions from low-volatility accumulation into a more active trend phase, buoyed by expanding volume and key component demand.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>Figure Technology Solutions said its consumer loan marketplace volume rose 127% year-over-year to $896 million in February 2026, compared with $395 million in February 2025.</li><li>The company also reported that its yield-bearing stablecoin in circulation reached $588 million, representing a 56% increase from January 2026.</li><li>Figure’s fourth-quarter EPS came in at $0.06, missing analyst estimates of $0.15.</li></ul>Figure Technology Solutions (FIGR) shares were in the spotlight on Tuesday after Mizuho analyst Dan Dolev lowered the firm’s price target to $55 from $64 while maintaining an ‘Outperform’ rating.&nbsp;Mizuho cited FIGR’s fourth-quarter 2025 results and its partnership with Agora Data as factors behind the updated target. Figure's "aggressive" expansion of its total addressable market and product range in the U.S. consumer credit market is encouraging, said Dolev.The partnership indicated Figure’s plans to enter the auto-loans market using its proprietary platform. Currently, the&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.mordorintelligence.com/industry-reports/auto-loan-market">global auto-loans market</a> stands at a market cap of $1.8 trillion, according to Mordor Intelligence.On Stockwits, the retail sentiment around&nbsp;<a href="https://stocktwits.com/symbol/FIGR/sentiment">Figure Technology Solutions (FIGR)</a> stock improved from ‘bearish’ to ‘neutral’ as chatter levels around it remained ‘low’ over the past day.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_03_10_at_12_38_27_PM_png_cd7aee4af8.webp" alt="Screenshot 2026-03-10 at 12.38.27 PM.png" width="1010" height="108"><figcaption>FIGR retail sentiment and message volume on March 10 as of 12:38 p.m. ET | Source: Stocktwits</figcaption></figure><h2 class="st-heading-2">Recent Loan Marketplace Growth</h2>Figure Technology Solutions reported full-year 2025 net revenue of $506.9 million, while net income reached $134.3 million and adjusted EBITDA totaled $251.2 million, according to the company’s earnings report.First-lien loans represented 19% of originations in its Consumer Loan Marketplace, up from 12% a year earlier. The average loan size was approximately $135,000, while second-lien loans were about $85,000, according to the company.Additionally, the firm reported that the volume of its consumer loan marketplace increased by 127% year over year to $896 million in February 2026, and the amount of yield-bearing stablecoin ($YLDS) in circulation increased by 56% from January to $588 million, indicating the increasing use of the company's blockchain-based settlement infrastructure.&nbsp;Diluted earnings per share (EPS) for the fourth quarter of 2025, however, came in at $0.06, falling short of analyst expectations of $0.15.Goldman Sachs cut Figure Technology's price target from $44 to $39 last week while maintaining a ‘Buy’ rating. Goldman said Figure's core business is expected to grow in the long term, while the firm expects higher volume as the usual winter slowdown in HELOC origination ends.Read also: <a href="https://stocktwits.com/news-articles/markets/cryptocurrency/winklevoss-bitcoin-transfer-gemini-wallets-130m-btc/cZdosauRI73">One of Bitcoin’s Earliest Billionaires Moved $130M In BTC To Hot Wallets, Sparking Sell Speculation</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the Figure Technology Solutions logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

FIGR Stock In Spotlight After Mizuho Cuts Price Target – But Analyst Finds ‘Aggressive’ Expansion Of Total Addressable Market Encouraging

Last week, Goldman Sachs cut its price target on the stock from $44 to $39 while maintaining a ‘Buy’ rating.

Equity

Last week, Goldman Sachs cut its price target on the stock from $44 to $39 while maintaining a ‘Buy’ rating.


FIGR_HELOC
Figure Heloc

Chart

News

Sentiment

Info

Historical Prices

Compact View

Poll

Latest FIGR_HELOC News

FIGR_HELOCFigure Heloc